DDI Between BI Empagliflozin (10773) and Verapamil

Summary

Relative bioavailability of BI 10773 given alone and together with verapamil

Timeline

Start

2011-01

Primary completion

2011-02

Completion

—

Publications

• Macha S, Sennewald R, Rose P, Schoene K, Pinnetti S, Woerle HJ, Broedl UC. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers. Clin Ther. 2013 Mar;35(3):226-35. doi: 10.1016/j.clinthera.2013.02.015.

Drugs

Indications

No indication recorded.